Radiation Oncology

Patient Information

Our Physicians

Treatment Machines

Hours of Operation

RTOG Research Protocols

Other Research Protocols

    Head & Neck

    Prostate

Residency Application

Physics

Biology

Atlas of Organs at Risk

Remote Support

Remote Support
OnCampus

Martin Colman, MD, FRCR, FACR

Title:
Professor and Chairman                              

Education:
University of the Witwatersrand, Johannesburg, South Africa MB, BCh   1964 Medical School
University of the Witwatersrand, Johannesburg, South Africa Mmed (RadT) 1971 Graduate Program
Royal Marsden Hospital & Univ. of London, England 1971 Nuclear Medicine
Royal Colleges of Physicians & Surgeons, England 1971 DMRT

Research and/or Professional Experience:
07/80 - 05/96 Associate Professor, division of Radiation Oncology, University of California, Irvine
07/77 - 12/92 Chief, Division of Radiation Oncology, University of California, Irvine
01/93 - 05/96 Acting Chairman, Department of Radiation Oncology
1978 - 1986 Consultant, Radiotherapy Service, VA Medical Center, Long Beach
1986- 1988 Acting Chief, Radiotherapy Service, VA Medical Center, Long Beach
1988- 1992 Staff Radiation Oncologist, Radiotherapy Service, VA Medical Center, Long Beach
06/96- Emeritus Professor, Department of Radiation Oncology, university of California, Irvine
04/96- Professor and Chairman, Department of Radiation Oncology, University of Texas Medical Branch at Galveston

Committees – National:
1977 – 1978 Committee Member, American Society of Therapeutic Radiology and Oncology
1978 - Committee Member, National Cancer Institute
1979 – 1987 Board of Directors, Committee Member, American Cancer Society
1979 – 1995 Committee Member, Radiation Research Society
1979 – 1987 Committee Member, Radiation Therapy Oncology Group
1980 – 1987 Committee Member, Gynecology Oncology Group
1987 – 1994 Examiner, American Board of Radiology

Honors:
1994 - F.R.C.R., Fellow of the Royal College of Radiology (by election)


Publications: (15 selected publications)
1. Redpath, J.L., Zabilansky, E. and Colman, M. The effect of Adriamycin on repair of sublethal damage and slow repair in irradiated mouse lung. Int’l’. J. Rad. Bio. 39:157-161, 1981.

Publications Con’t. Principal Investigator: Colman, Martin

2. Colman, M.; Zabilansky, E. and Redpath, J.L.. Modification of the radiation response of mouse lung by Actinomycin D: Dependence of interval between radiation and drug treatments. IJROBP 8:511-512.
3. Colman, M. Choice of treatment for early Hodgkin’s Disease. Hem. Onc. 2:2-3, 1984
4. Sun, C.; Redpath, J.L.; Colman, M. and Stanbridge, E.J. Repair of potentially lethal radiation damage in confluent and non-confluent cultures of human hybrid cells. Int’l. J. Rad. Bio. 49:398-401, 1986.
5. Horwich, A.; Easton, D.; Nogueira-Costa, R.; Liew, K.H.; Colman, M. and Peckham, M.J. An analysis of prognostic factors in early stage Hodgkin’s disease. Radiotherapy and Oncology 7:95-1061, 1986.
6. Qu, L.Z.; Nalcioglu, O.; Roech, W.W.; Rabbani, B. and Colman, M. video based x-ray computed tomography. IEEE Transactions on Nuclear Science 33:527-530, 1986.
7. Redpath, J.L.,; Sun, C.; Colman, M. and Stanbridge, E.J. Radiobiological studies of human hybrid cells (skin fibroblasts x HeLa) and their tumorigenic segregants. Int’l J. Rad. Bio. 48:479-483, 1985.
8. Redpath, J.L.; Sun, C.; Colman, M. and Stanbridge, E.J. Neoplastic transformation of human hybrid cells by gamma radiation: A quantative assay. Rad. Res. 110:468-472, 1987.
9. Colman, M.; Bhatt, S.; Candelaria, M.; Sun, C. and Redpath, J.L. A comparison of the radiation sensitivities of non-tumorigenic and tumorigenic human hybrid cell lines. Int’l. J. of Rad. Bio. 53:609-616, 1988.
10. Colman,, M.; Easton, D.F.; Horwich, A. and Peckham, M.J. Second malignancies and Hodgkin’s disease – The Royal Marsden Hospital experience. Radiotherapy and Oncology 11:229-238, 1988.
11. Sun, C.; Colman, M. and Redpath, J.L. Suppression of the radiation –induced expression of a tumor-associated antigen in human cell hybrids by the protease inhibitor antipain. Carcinogenesis 9:2333-2335, 1988.
12. Brada, M.; Ashley, S.; Nicholls, J.; Wist, E.; Colman, M.; McElwain, T.J. Selby, P.; Peckhan, M.J. and Horwich, A. Stage III Hodgkin’s disease – long-term results following chemotherapy, radiotherapy and combined modality therapy. radiotherapy and oncology, 14:185-198, 1989.
13. Kucera, P.R.; Berman, M.L.; Treadwell, P.; Sheets, E.E.; Micha, J.P.; Rettenmaier, M.A.; Colman, M. and DiSaia, P.J. Whole abdominal radiation therapy in patients with minimal residual epithelial ovarian cancer. Gyn. Onc. 36:338-342, 1990.
14. Kurohara, W.; Colman, M.; Nagourney, R.A.; Weisenthal, L.M.; Swingle, K. and Redpath, J.L. Radiation response of cells from human tumor biopsies as assessed by a dye exclusion technique: A possible predictive assay. Int’l J. of Rad. Bio. 56:767-770, 1989.
15. Redpath, J.L.; Sun, C.; Colman, M.; Loucas, B.; Muhlman-Diaz, M. and Bedford, J.S. lack of differential G2 chromosomal radiosensitivity between non-tumorigenic and tumorigenic human hybrid cells (HeLa x skin fibroblasts). Int’l . J. of Rad. Bio. 62:679-685, 1992.